And renewed existing plans in Australia and New Zealand.

Cambridge Labs announces Spanish authorization of Tetrabenazine Cambridge Laboratories Limited offers announced that its flagship product Tetrabenazine, has received marketing acceptance in Spain from the Agencia Espanola de Medicamentos y Productos Sanitarios. THE BUSINESS also announces that it has signed distribution agreements for Tetrabenazine in Finland and Taiwan recently, and renewed existing plans in Australia and New Zealand. Tetrabenazine will end up being marketed as NITOMAN in Spain by Cambridge’s marketing partner UCB upon successful completion of most related procedures for anthrax infections . It’s been approved for the treating movement disorders associated with Huntington’s disease, a condition that there is major unmet medical want. Related StoriesUCSF analysis on mood disorders aims to advance understanding and treatment of depressionGeneral psychiatric support warranted in MS patientsDiscovery presents promising alternative to current therapies for AMD and ROPCambridge has renegotiated its agreements with UCB in Spain and Portugal, offering UCB ten season exclusive marketing rights to Tetrabenazine in Spain. UCB, a worldwide biopharmaceutical company, is targeted on severe diseases in three therapeutic areas – inflammation, neurology and oncology. The renegotiated terms follow UCB’s acquisition of Celltech, Cambridge’s previous partner in Spain and Portugal, and the more recent merger of UCB with Schwarz Pharma. UCB is currently along the way of applying for cost and reimbursement in Spain and expects to have this process completed in the first half of 2009. Tag Evans, CEO of Cambridge, said: ‘The granting of a license for Tetrabenazine in Spain follows a number of launches in key global territories, especially the US where the product was launched last month and completes the authorization process in the main 5 EU territories. The continued world-wide rollout of Tetrabenazine, with fresh agreements signed in Finland and Taiwan is normally affirmation of Cambridge’s dedication to offering Huntington’s disease patients with this essential treatment. We are very happy to possess partnered in Spain with UCB particularly, one of Europe’s leading neurology players.’ A spokesperson from UCB said: ‘Our experience within the CNS arena allows us to increase the value of the potential fresh therapy for patients, doctors and our shareholders.’.

http://cipro500hcl.com/

IS IT POSSIBLE TO Get Genital Herpes From a Cool Sore? Can you get genital herpes from a cold sore? – Lucy* Yes — it is possible to get genital herpes from oral sex. Genital herpes is caused by the herpes simplex virus . There are two types of herpes infections — HSV-1 and HSV-2. Genital herpes is normally caused by HSV-2; oral herpes is usually caused by HSV-1. However, genital herpes could be due to HSV-1 also. Someone with HSV-1 can transmit the virus through oral contact with someone else’s genitals, anus, or mouth, even if they don’t have sores that are visible at the time. Other than abstinence the simplest way to help prevent herpes is to use a condom during any kind of sex . Girls must have their partners make use of a dental dam whenever they receive oral sex to help drive back genital herpes. And if either partner includes a sore, you need to not have sex before sore has solved.

Other Posts From Category "dermatology":

Related Posts